Establishing the first clinical guidelines for Nummular Eczema

Our latest study, published in the Journal of the European Academy of Dermatology and Venereology, set out to close a gap in dermatological care.

The takeaway: Despite placing a substantial burden on patients - often causing sleep disturbance and psychological distress - there were previously no established clinical guidelines to support the diagnosis and management of Nummular Eczema.

Through a Delphi process, this study developed the first expert, consensus-based recommendations for the condition.

We've summarised the key takeaway message below.

To bring this study to life, Momentum Data provided end-to-end project support.

Working alongside 63 experts across 16 countries, we managed the panel and executed a 2-round survey that ultimately achieved a 76.6% final consensus rate on 64 different clinical statements.

Our core contributions included:

  • Study Conception and Delphi Design

  • Survey Execution and Panel Management

  • Statistical Analysis and Data Visualisation

  • Medical Writing and Publication Support

Read the full paper here

Turning real world data into impactful evidence

Ultimately, our goal is simple:
To produce dynamic, engaging outputs that truly tell the story of the evidence - and make sure it’s heard.

Previous
Previous

Our latest work on sleep disturbance in atopic dermatitis

Next
Next

Does Alopecia Areata weaken the immune system?